Evonile Pharma Ltd Gains 2.45%: Key Market Reactions and Volatility Insights
2026-11-15 09:00:06Key Events This Week Nov 09: Strong opening with 5.62% gain to Rs.1,567.38 Nov 11: Significant gap down and intraday low at Rs.1,553.1 amid market concerns Nov 12: Continued recovery with 0.66% gain to Rs.1,583.60 Nov 13: Sharp decline of 4.00% closing at Rs.1,520.30 Week Open Rs.1,483.94 <div class="...
Read More
Novartis India Ltd Reports Sharp Financial Decline in Q3 2026 Amid Market Volatility
2026-11-04 11:00:14Novartis India Ltd has reported a significant downturn in its financial performance for the quarter ended September 2026, marking a stark reversal from its previous trend of moderate growth. The company’s latest results reveal deep contractions in revenue, profitability, and margins, prompting a downgrade in its Mojo Grade to Sell from Hold as of 21 October 2026.
Read More
Novartis India Ltd is Rated Hold by MarketsMOJO
2026-11-02 10:10:50Novartis India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 October 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 02 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Novartis India Ltd Hits Intraday Low Amid Price Pressure on 30 Oct 2026
2026-10-30 15:16:25Novartis India Ltd experienced a notable decline today, touching an intraday low of Rs 1,693, reflecting a 6.63% drop from previous levels. The stock underperformed its sector and broader market indices, facing immediate selling pressure amid mixed technical signals and a cautious market environment.
Read MoreNovartis India Ltd Falls 3.47%: 6 Key Factors Driving the Weekly Volatility
2026-10-25 10:00:06Key Events This Week 19 Oct: Technical momentum shifts amid mixed indicator signals 21 Oct: Intraday low hit with sharp 8.01% drop 22 Oct: Downgrade to Hold amid valuation concerns 23 Oct: Strong intraday surge of 8.78% Weekly Summary: Stock closes at Rs.1,834.75 (-3.47%), Sensex down 3.75% Week Open Rs.1,922....
Read More
Novartis India Ltd Surges 8.76% to Day's High of Rs 1886.45 — Outperforms Sector by 11.61 Percentage Points
2026-10-23 15:16:23The Sensex declined 0.47% on 23 Jun 2026, while Novartis India Ltd surged 8.76%, marking a striking 11.61-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This sharp intraday rally rewrites the short-term narrative for the stock, which had been under pressure in recent weeks.
Read More
Novartis India Ltd Downgraded to Hold Amid Mixed Technicals and Valuation Concerns
2026-10-22 08:22:58Novartis India Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 21 Oct 2026. This revision reflects a nuanced reassessment across four critical parameters: Quality, Valuation, Financial Trend, and Technicals. Despite strong long-term returns and robust financials, evolving market dynamics and technical indicators have prompted a more cautious stance.
Read More
Novartis India Ltd Sees Mixed Technical Signals Amid Price Momentum Shift
2026-10-22 08:01:46Novartis India Ltd has experienced a notable shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. This change comes amid a sharp price correction and mixed signals from key technical indicators such as MACD, RSI, and moving averages, signalling a cautious outlook for investors in the Pharmaceuticals & Biotechnology sector.
Read More
Novartis India Ltd Technical Momentum Shifts Signal Bullish Outlook
2026-10-21 08:02:38Novartis India Ltd has demonstrated a significant shift in price momentum, upgrading its technical outlook from mildly bullish to bullish. Supported by strong weekly and monthly MACD signals and daily moving averages, the pharmaceutical small-cap is showing renewed investor interest despite mixed RSI readings and neutral volume trends.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
16-Nov-2026 | Source : BSENewspaper Publication w.r.t. the dispatch of Letter of Offer and issue materials for the Rights Issue of the Equity Shares of the Company.
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
13-Nov-2026 | Source : BSEScrutinizers Report for the voting results of the Postal Ballot 02/2026-27
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
13-Nov-2026 | Source : BSEOutcome of the Postal Ballot 02/2026-27 along with the Voting Results.
Corporate Actions
No Upcoming Board Meetings
Evonile Pharma Ltd has declared 500% dividend, ex-date: 23 Jul 25
No Splits history available
No Bonus history available
Evonile Pharma Ltd has announced 5:12 rights issue, ex-date: 11 Nov 26